Skip Navigation



Annals of Oncology Advance Access published online on May 12, 2007
Annals of Oncology, doi:10.1093/annonc/mdm110
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
18/7/1209    most recent
mdm110v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Plonquet, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plonquet, A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology

Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2–3 diffuse large B-cell lymphoma

A Plonquet1, C Haioun2, J-P Jais3, A-L Debard4, G Salles5, M-C Bene6, P Feugier7, C Rabian8, O Casasnovas9, M Labalette10, E Kuhlein11, J-P Farcet1, J-F Emile12, C Gisselbrecht13, M-H Delfau-Larue1,* On behalf of GELA (Groupe d'étude des lymphomes de l'adulte)

1 Service d'Immunologie Biologique, Institut National de la Santé et de la Recherche Médicale (INSERM), U617, Créteil
2 Service d'Hématologie clinique, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Henri Mondor-Albert Chenevier, Université Paris 12, Faculté de Médecine, Créteil
3 Faculté de Médecine, Université René Descartes, AP-HP, Hôpital Necker-Enfants Malades, Service de Biostatistique et Informatique Médicale, Paris
4 Laboratoire d'Immunologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud Pierre Bénite, Lyon
5 Service d'Hématologie, Hospices Civils de Lyon, Pierre-Bénite
6 Laboratoire d'Immunologie Centre Hospitalier Universitaire (CHU) Nancy Brabois, Vandoeuvre les Nancy
7 Service d' Hématologie Adulte, Faculté de Médecine, Université Henri Poincaré Nancy 1, CHU Nancy Brabois, Vandoeuvre les Nancy
8 Laboratoire d'Immunologie et Histocompatibilité, Université Paris 7, AP-HP, Hôpital Saint-Louis, Paris
9 Service d'Hematologie Clinique, CHU Dijon, Dijon
10 Laboratoire d'Immunologie, EA 2686 CHRU Lille
11 Laboratoire d'Immunologie, CHU Rangueil, Toulouse
12 Service d'Anatomie Pathologique, INSERM U602, Université Versailles-Saint Quentin, AP-HP, Hôpital Ambroise Pare, Boulogne
13 Service d'Hématologie–Oncologie Adultes, Université Paris 7, AP-HP, Hôpital Saint-Louis, Paris, France

* Correspondence to: Prof. M.-H. Delfau-Larue, Laboratoire d'Immunologie Biologique—Hôpital Henri Mondor, 51, ave du Maréchal de Lattre de Tassigny, 94010 Creteil, France. Tel: +33-1-49-81-26-65; Fax: +33-1-49-81-28-97; E-mail: marie-helene.delfau-larue{at}hmn.aphp.fr

Background: Lymphocytopenia is a prognostic factor in Hodgkin's disease. In diffuse large B-cell lymphoma (DLBCL), data are much less established, in spite of numerous reports on immune system–lymphoma interactions. This study addresses the prognostic value of blood lymphocyte subsets at diagnosis in DLBCL.

Patients and methods: Absolute values of blood lymphocyte subsets and monocytes were prospectively determined by flow cytometry in 140 patients with 2 or 3 adverse age-adjusted International Prognostic Index (aaIPI) factors included in a Groupe d'Etude des Lymphomes de l'Adulte protocol (LNH98B3). Absolute cell counts at diagnosis and aaIPI were evaluated with regard to clinical outcome.

Results: Low median cell counts of 337, 211, and 104/µl were evidenced for the CD4+, CD8+ T, and natural killer (NK) cells, respectively. In univariate analysis, only NK cell count [odds ratio (OR) = 1.81 (1.27, 2.57), P = 0.001] and aaIPI [OR = 2.29 (0.95, 5.45), P = 0.06] were associated with induction treatment response. Low NK cell count [Hazard ratio (HR) = 1.27 (1.06, 1.52), P = 0.01] and aaIPI 3 [HR = 1.95 (1.20, 3.16), P = 0.01] were also associated with a shorter event free survival (EFS). In multivariate analysis, NK cell count was associated with response [OR = 1.77 (1.24, 2.54), P = 0.002] and EFS [HR = 1.25 (1.04, 1.50) P = 0.02] independently of aaIPI.

Conclusions: This study shows an association between circulating NK cell number and clinical outcome in DLBCL, possibly important in the context of the broadening use of rituximab, a likely NK-dependant therapy.

Diffuse large B-cell lymphoma, lymphopenia, NK cells, prognosis

Received for publication November 27, 2006. Revision received February 2, 2007. Accepted for publication February 21, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
M.-K. Song, J.-S. Chung, Y.-M. Seol, S.-G. Kim, H.-J. Shin, Y.-J. Choi, G.-J. Cho, and D.-H. Shin
Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy
Ann. Onc., January 1, 2010; 21(1): 140 - 144.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
C. Haioun, N. Mounier, J. F. Emile, D. Ranta, B. Coiffier, H. Tilly, C. Recher, C. Ferme, J. Gabarre, R. Herbrecht, et al.
Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma
Ann. Onc., December 1, 2009; 20(12): 1985 - 1992.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Ray-Coquard, C. Cropet, M. Van Glabbeke, C. Sebban, A. Le Cesne, I. Judson, O. Tredan, J. Verweij, P. Biron, I. Labidi, et al.
Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
Cancer Res., July 1, 2009; 69(13): 5383 - 5391.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.